Radiotherapy Market Seeing the Rise of 6.2% CAGR to 2020 Led by External Beam Radiotherapy Segment

The global radiotherapy market is expected to reach USD 7,544.8 million by 2020 from USD 5,585.0 million in 2015, at a CAGR of 6.2% between 2015 and 2020 driven by improving healthcare infrastructure and supportive government activities.

On the basis of technology, the global market is segmented into external beam radiotherapy (intensity-modulated radiation therapy, image-guided radiotherapy, tomotherapy, stereotactic technology, 3D conformal radiotherapy, proton beam therapy, and volumetric modulated arc therapy), internal beam radiotherapy (high dose rate and low dose rate), and systemic radiation therapy.

The radiotherapy market is expected to reach USD 7,544.8 Million by 2020 from USD 5,585.0 Million in 2015, at a CAGR of 6.2% between 2015 and 2020. A strong trend of increasing incidence of cancer cases across the globe majorly drives the growth of the market.

Complete research of 48 market data tables & 91 figures spread through 177 pages and in-depth TOC on "Radiotherapy Market" at .

This report broadly segments the global market into external beam radiotherapy, internal radiotherapy/brachytherapy, and systemic radiation therapy. In 2015, the external beam radiotherapy segment is expected to account for the largest share of the global market. By product, the external beam radiotherapy is further classified into compact advanced radiotherapy devices (Cyberknife, Gammaknife, and Tomotherapy), proton therapy systems (cyclotrons and synchrotrons), and electron emitting high energy linear accelerators.

The internal radiotherapy market, by product is further segmented into seeds, applicators & afterloaders, and electronic brachytherapy. Based on application, the external beam radiotherapy market is segmented into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer, and others (spine cancer and brain cancer). The internal radiotherapy, by applications is further divided into prostate cancer, gynaecological cancer, breast cancer, cervical cancer, penile cancer, and others (lung cancer and head & neck cancer). In 2015, the prostate cancer application segment is expected to account for the largest share in both external beam radiotherapy market as well as internal radiotherapy market, by application.

This report covers the radiotherapy market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America is expected to command the largest share of the global market. However, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2015 to 2020, due to increasing prevalence of cancer, rapidly growing aging population, and favorable government initiatives in this region.

Major players in the global Radiotherapy market include Varian Medical Systems, Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), Ion Beam Applications SA (Belgium), C. R. Bard, Inc. (U.S.), IsoRay Medical, Inc. (U.S.), Nordion, Inc. (Canada), RaySearch Laboratories AB (Sweden), Mevion Medical Systems, Inc. (U.S.), and Mitsubishi Electric Corporation (Japan). Ask for the discount before order a copy of Radiotherapy Market by Technology (External (IGRT, IMRT, VMAT, & Stereotactic), Brachytherapy (LDR & HDR), & Systemic Radiotherapy), Product (Cyberknife, Gammaknife, Linac, Proton Beam), & Application (Prostate & Breast Cancer)) - Global Forecasts to 2020 research report at .

In 2015, the image-guided radiotherapy technology is expected to account for the largest share of the global market, by technology. Other growth factors include technological advancements in radiotherapy products, increasing symposiums driving investments in radiotherapy, rise in number of geriatric population and growing adoption of radiotherapy devices and procedures.

However, lack of adequate infrastructure & healthcare expenditure, shortage of trained personnel, and unfavourable healthcare reforms in the U.S. are some of the key factors restraining the growth of this market. In addition to this, challenges associated with difficulty in visualizing tumours and affordability & accessibility of treatment also limits the growth of the radiotherapy market.

On a related note, anotehr research on North American Nuclear Medicine/Radiopharmaceuticals Market Forecasts to 2020 says, the market is poised to reach USD 2.98 billion by 2020 from USD 1.97 billion in 2015, growing at a CAGR of 8.6% during the forecast period of 2015 to 2020. In 2015, the diagnostic segment accounted for the largest share of the North American nuclear medicine/radiopharmaceuticals market, by type. Companies like Cardinal Health Inc., Mallinckrodt plc, GE Healthcare, Lantheus Medical Imaging, Inc., Bayer Healthcare, Bracco Imaging S.p.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Advanced Accelerator Applications S.A. and IBA Molecular Imaging have been profiled in this 180 pages research report available at .

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: ReportsnReports
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar
Phone: +1-888-391-5441

Release ID: 110442